| Literature DB >> 35408606 |
Svetlana I Dorovskikh1,2, Denis E Tryakhov2, Darya D Klyamer1, Alexander S Sukhikh1,2, Irina V Mirzaeva1,2, Natalia B Morozova1, Tamara V Basova1.
Abstract
To search for new suitable Pd precursors for MOCVD/ALD processes, the extended series of fluorinated palladium complexes [Pd(CH3CXCHCO(R))2] with β-diketone [tfa-1,1,1-trifluoro-2,4-pentanedionato (1); pfpa-5,5,6,6,6-pentafluoro-2,4-hexanedionato (3); hfba-5,5,6,6,7,7,7-heptafluoro-2,4-heptanedionato (5)] and β-iminoketone [i-tfa-1,1,1-trifluoro-2-imino-4-pentanonato (2); i-pfpa-5,5,6,6,6-pentafluoro-2-imino-4-hexanonato (4); i-hfba-5,5,6,6,7,7,7-heptafluoro-2-imino-4-heptanonato (6)] ligands were synthesized with 70-80% yields and characterized by a set of experimental (SXRD, XRD, IR, NMR spectroscopy, TG) and theoretical (DFT, Hirshfeld surface analysis) methods. Solutions of Pd β-diketonates contained both cis and trans isomers, while only trans isomers were detected in the solutions of Pd β-iminoketonates. The molecules 2-6 and new polymorphs of complexes 3 and 5 were arranged preferentially in stacks, and the distance between molecules in the stack generally increased with elongation of the fluorine chain in ligands. The H…F contacts were the main ones involved in the formation of packages of molecules 1-2, and C…F, F…F, NH…F contacts appeared in the structures of complexes 4-6. The stability of complexes and their polymorphs in the crystal phases were estimated from DFT calculations. The TG data showed that the volatility differences between Pd β-iminoketonates and Pd β-diketonates were minimized with the elongation of the fluorine chain in the ligands.Entities:
Keywords: DFT calculations; Hirshfeld surface analysis; TG study; crystal structure; palladium(II) β-diketonate derivatives
Mesh:
Substances:
Year: 2022 PMID: 35408606 PMCID: PMC9000314 DOI: 10.3390/molecules27072207
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Graphical illustration of [Pd(CH3CXCHCO(R))2] complexes and the abbreviations for the ligands, depending on the combination of donor atoms (X) and substituents (R).
| Graphical Illustration of [Pd(CH3CXCHCO(R))2] | Ligand | Abbreviations for | Abbreviations for Complexes | |
|---|---|---|---|---|
| R | X | |||
|
| CF3 | O | tfa |
|
| NH | i-tfa |
| ||
| C2F5 | O | pfpa |
| |
| NH | i-pfpa |
| ||
| C3F7 | O | hfba |
| |
| NH | i-hfba |
| ||
Scheme 1The general scheme for synthesis of the complexes 1–6.
Figure 1Two isomers of 2: trans and cis.
Calculated energy differences between cis and trans isomers (ΔE, kJ/mol) and the cis:trans isomer ratio, based on the NMR data.
| 1 | 2 | 3 | 4 | 5 | 6 | |
|---|---|---|---|---|---|---|
| ΔE, kJ/mol | 1.92 | 18.24 | 1.72 | 19.33 | 2.18 | 23.58 |
| 43:57 | 3:97 | 36:64 | - | 36:64 | - |
Figure 2Experimental IR spectra of complexes 3–6.
Unit cell parameters and refinement statistics.
| Identification Code | 2 | 3_1 | 3-2 | 5_1 | 5_2 | 5_3 | 4 | 6 |
|---|---|---|---|---|---|---|---|---|
| Empirical formula | C10H10F6N2O2Pd | C12H8F10O4Pd | C12H8F10O4Pd | C14H8F14O4Pd | C14H8F14O4Pd | C14H8F14O4Pd | C12H10F10N2O2Pd | C14H10F14N2O2Pd |
| Formula weight | 410.60 | 512.58 | 512.58 | 612.60 | 612.60 | 612.60 | 510.62 | 610.64 |
| Temperature/K | 250.0 | 150 | 220.0 | 150.0 | 220 | 250.0 | 150 | 150.0 |
| Crystal system | monoclinic | triclinic | monoclinic | monoclinic | triclinic | triclinic | monoclinic | triclinic |
| Space group | P21/n | P-1 | P21/c | C2/c | P-1 | P-1 | P21/c | P-1 |
| a/Å | 11.3784(9) | 4.9017(2) | 10.8322(5) | 23.7565(8) | 5.7613(3) | 9.3089(2) | 6.7968(6) | 5.0366(6) |
| b/Å | 5.0152(4) | 6.9392(3) | 17.2176(8) | 9.0373(3) | 13.0127(5) | 10.5336(3) | 20.3999(16) | 9.4484(11) |
| c/Å | 11.6614(8) | 11.7607(5) | 9.2280(4) | 8.9907(3) | 14.4882(6) | 12.1779(3) | 11.6796(10) | 10.7492(11) |
| α/° | 90 | 73.869(2) | 90 | 90 | 64.951(2) | 101.0370(10) | 90 | 72.759(5) |
| β/° | 94.072(3) | 81.705(2) | 105.107(2) | 94.0550(10) | 79.866(2) | 109.5360(10) | 90.504(3) | 81.207(6) |
| γ/° | 90 | 85.553(2) | 90 | 90 | 78.423(2) | 107.0890(10) | 90 | 76.160(6) |
| Volume/Å3 | 663.78(9) | 379.96(3) | 1661.58(13) | 1925.42(11) | 958.92(8) | 1018.54(4) | 1619.4(2) | 472.51(9) |
| Z | 2 | 1 | 4 | 4 | 2 | 2 | 4 | 1 |
| ρcalcg/cm3 | 2.054 | 2.240 | 2.049 | 2.113 | 2.122 | 1.997 | 2.094 | 2.146 |
| μ/mm−1 | 1.475 | 1.355 | 1.239 | 1.117 | 1.121 | 1.056 | 1.266 | 1.133 |
| F(000) | 400.0 | 248.0 | 992.0 | 1184.0 | 592.0 | 592.0 | 992.0 | 296.0 |
| 2Θ range for data collection/° | 4.834 to 56.586 | 6.116 to 66.582 | 3.894 to 56.854 | 4.824 to 66.27 | 5.54 to 72.892 | 3.748 to 61.044 | 3.488 to 56.622 | 3.982 to 66.536 |
| Reflections collected | 6711 | 4812 | 18767 | 13865 | 18778 | 18514 | 15558 | 6959 |
| Independent reflections | 1647 [Rint = 0.0403, Rsigma = 0.0338] | 4812 [Rint = ?, Rsigma = 0.0363] | 4138 [Rint = 0.0395, Rsigma = 0.0351] | 3651 [Rint = 0.0282, Rsigma = 0.0256] | 9200 [Rint = 0.0251, Rsigma = 0.0289] | 6206 [Rint = 0.0262, Rsigma = 0.0288] | 4015 [Rint = 0.0763, Rsigma = 0.0875] | 3588 [Rint = 0.0506, Rsigma = 0.0794] |
| Data/restraints/parameters | 1647/0/102 | 4812/0/126 | 4138/0/246 | 3651/0/152 | 9200/0/385 | 6206/27/303 | 4015/8/258 | 3588/1/156 |
| Goodness-of-fit on F2 | 1.058 | 1.086 | 1.026 | 1.044 | 1.054 | 1.037 | 1.026 | 1.045 |
| Final R indexes (I ≥ 2σ (I)) | R1 = 0.0325, wR2 = 0.0832 | R1 = 0.0275, wR2 = 0.0671 | R1 = 0.0376, wR2 = 0.0898 | R1 = 0.0210, wR2 = 0.0537 | R1 = 0.0284, wR2 = 0.0724 | R1 = 0.0537, wR2 = 0.1631 | R1 = 0.0514, wR2 = 0.0856 | R1 = 0.0300, wR2 = 0.0630 |
| Final R indexes (all data) | R1 = 0.0461, wR2 = 0.0929 | R1 = 0.0283, wR2 = 0.0676 | R1 = 0.0546, wR2 = 0.0981 | R1 = 0.0254, wR2 = 0.0567 | R1 = 0.0372, wR2 = 0.0798 | R1 = 0.0736, wR2 = 0.1812 | R1 = 0.1266, wR2 = 0.1061 | R1 = 0.0357, wR2 = 0.0644 |
| Largest diff. peak/hole/e Å−3 | 1.02/−0.78 | 0.95/−0.55 | 0.89/−0.66 | 0.90/−0.69 | 0.80/−0.86 | 0.94/−0.58 | 1.24/−0.85 | 0.53/−1.20 |
Figure 3Molecular packing diagrams for the complexes 3–6 and their polymorphs.
Bond lengths and angles of [Pd(CH3CXCHCO(R))2] complexes.
| Parameter | Palladium β-Diketonates | Palladium β-Iminoketonates | |||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | 3_1 | 3_2 | 5_1 | 5_2 | 5_3 | 2 [ | 4 | 6 | |
| Pd–O/Å | 1.979/ | 1.977/ | 1.982–1.988 | 1.979–1.981 | 1.979–1.980 | 1.968–1.977 | 1.986 | 1.979–1.983 | 1.978 |
| Pd–N/Å | N/A | N/A | N/A | N/A | N/A | N/A | 1.983 | 1.973–1.980 | 1.979 |
| ∠O– Pd –O/° | 94.803 | 95.026 | 94.542/94.638 | 94.652 | 94.417/ | 94.367/ | N/A | N/A | N/A |
| ∠N– Pd –O/° | N/A | N/A | N/A | N/A | N/A | N/A | 92.645 | 93.131/93.421 | 92.946 |
| ∠ (two metallocycles)/° | 0 | 0 | 2.306 | 0 | 0 | 0 | 0 | 0 | 0 |
| ∠ stacking/° | 45.407 | N/A | 42.732 | 40.580 | 53.35 | 42.279/ | 47.590 | 6.261/ | 47.591 |
| ∠ within stack/° | 0 | N/A | 10.611 | 10.149 | 0 | 11.711 | 0 | 0.29 | 0 |
| distance between molecules in stack/Å | 3.362 | 3.589 | 3.357–3.440 | 3.414 | 3.439 | 3.444–3.494 | 3.382 | 3.394 | 3.397 |
| Pd…Pd/Å | 4.788 | 4.902 | 4.636 | 4.495 | 5.761 | 4.654 | 5.015 | 3.398 | 5.037 |
Figure 4XRD data for the complexes 3–6 (a–f), including 5 polymorphs (c–e), compared with the corresponding theoretical diffractograms on the basis of the SXRD data.
Figure 5Hirshfeld surfaces for Pd β-diketonates, mapped with the dnorm property (range from −0.18 to 1.2).
Figure 6Hirshfeld surfaces for Pd β-iminoketonates, mapped with the dnorm property (range −0.18 to 1.2).
Figure 7Hirshfeld surfaces for [Pd(CH3CXCHCO(R))2] complexes, mapped with the shape index property (range −1 to 1).
Lattice binding energies per molecule (EvdW), molecular deformation energies (Edef), and total lattice energies per molecule (Elatt) for complexes 1–6.
| Complex | EvdW, kJ/mol | Edef, kJ/mol | Elatt, kJ/mol |
|---|---|---|---|
|
| 139.5 | 10.8 | 128.7 |
|
| 134.4 | 36.2 | 98.2 |
|
| 132.0 | 5.3 | 126.7 |
|
| 130.4 | 56.9 | 73.5 |
|
| 149.5 | 28.4 | 121.2 |
|
| 167.2 | 5.9 | 161.4 |
|
| 138.2 | 5.5 | 132.6 |
|
| 134.8 | 17.1 | 117.7 |
|
| 150.6 | 23.1 | 127.5 |
Figure 8Comparison of bond lengths in the molecules of complexes 1–6 in the crystal lattice (SXRD data) and in the gas phase (optimized geometry).
Figure 9TG curves of complexes 1–6.